Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

Some drugs have gained approval for new uses, while others like tricyclic antidepressants and aspirin show promise but aren't yet approved for these uses.

Oral cyclosporin doesn't stop hair loss.

Nanostructured lipid carriers are effective for treating hyperpigmentation in women aged 30-40.

These specific gene polymorphisms are not linked to Alopecia Areata in Egyptians.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

Oral ulcers are common in SLE patients and often link to other symptoms.

Pranlukast and mirabegron may work as new diabetes drugs.

The microbiome may be linked to hair loss and could be a target for new treatments.

COVID-19 can cause skin issues like "COVID toes," rashes, hair loss, and hand eczema, and dermatologists are important for recognizing these signs.

Nanoparticle-based herbal remedies could be promising for treating hair loss with fewer side effects and lower cost, but more research is needed.

Different hair disorders have specific treatments and outcomes, with some resolving on their own and others requiring medication or emotional support.

The Biofield Energy Treated herbal mixture increased hair growth in mice compared to the untreated mixture.

Hidradenitis Suppurativa is likely an autoinflammatory disease, and better understanding its causes could improve treatments.

Some hair loss disorders cause permanent loss due to scarring, and treatments like steroids don't always work well.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

A specific DNA sequence caused hair loss in male mice by activating immune cells and increasing a certain immune signal.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

Minoxidil 2% is more effective than tacrolimus 0.1% for hair regrowth in mild to moderate patchy hair loss, and combining both might give better results.

The document emphasizes early detection and treatment of men's skin conditions and recommends protective measures and appropriate treatments for different age groups.

Alopecia areata is a reversible, autoimmune-related hair loss that can have significant emotional impact and uncertain treatment effectiveness.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

Mesenchymal stem cells show promise for treating various skin conditions and may help regenerate hair.

Graft rejection in a hand transplant may trigger hair loss due to autoimmune responses.

Methotrexate is not proven effective for inducing remission in ulcerative colitis.

Methotrexate is not proven to maintain remission in ulcerative colitis.

Cyclosporin A promotes hair cell growth and affects protein kinase C levels.

Tailored treatments for alopecia areata are recommended based on severity and patient needs.